Key result
Transcatheter aortic-valve implantation successfully reduced the trans-aortic mean pressure gradient from 53 mmHg to 13 mmHg and resolved symptoms in a 76-year-old high-risk patient with severe aortic stenosis.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
TAVI can be safely and effectively performed in elderly patients with severe aortic stenosis and very high surgical risk due to comorbidities like end-stage renal disease.
Aortic stenosis is the most frequent type of valvular heart disease in adult. Approximately 2-7% of the population over the age of 65 suffer from aortic valve stenosis. Due to the increasing average life expectancy in Korea, degenerative aortic stenosis is increasing and becoming a troublesome health problem in older population. Because older patients with severe degenerative aortic stenosis have many other medical conditions so they are not suitable candidate for surgery. Recently, transcatheter aortic-valve implantation (TAVI) has been suggested as a less invasive treatment for patients with high perioperative risk. We report a successful TAVI case in severe aortic stenosis patient with high perioperative risk.
No takes yet. Share an insight, caveat, or question.
Jo et al. (2013) conducted a case report in Severe aortic stenosis (n=1). Transcatheter aortic-valve implantation (TAVI) was evaluated on Trans-aortic mean pressure gradient. Transcatheter aortic-valve implantation successfully reduced the trans-aortic mean pressure gradient from 53 mmHg to 13 mmHg and resolved symptoms in a 76-year-old high-risk patient with severe aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: